Drugs with this side effect as MedDRA Preferred Term
- 5-fluorocytosine
- APAs
- Anidulafungin
- Hypoglycaemia: 6.87% - 8%
- CAS 76095-16-4
- D-penicillamine
- FK463
- Hypoglycaemia: 4.66% - 6.93%
- Fe(III
- Humalog
- Insulin
- Hypoglycaemia: very common, 0.296% - 67%
- Hypoglycaemic episode
- L-Dmp
- LY146032
- Lantus
- Hypoglycaemia: 25.5% - 33%
- Hypoglycemic reaction: 2.56% - 3.42%
- Hypoglycaemic episode
- Leuprorelin
- Lisinopril
- Hypoglycaemia: very rare, postmarketing
- Hypoglycemic reaction
- Lyxumia
- Meropenem anhydrous
- NTBC
- NovoLog
- Hypoglycaemia: postmarketing, 27% - 76%
- Hypoglycemic reaction
- Hypoglycaemic episode: postmarketing
- Nuvocid
- Octreotide
- Hypoglycaemia: common, 0-2%
- PGE1
- SOM230
- Hypoglycaemia: 3.75% - 14.6%
- Saxagliptin
- Hypoglycaemia
- Hypoglycemic reaction
- Signifor
- Hypoglycaemia: 3.75% - 14.6%
- Symlin
- acetazolamide
- alogliptin
- alosetron
- amphotericin B
- aripiprazole
- Hypoglycaemia
- Hypoglycemic reaction
- arsenic
- arsenic trioxide
- aspirin
- atazanavir
- atorvastatin
- atovaquone
- Hypoglycaemia: 1% - 15.5%
- atropine
- avanafil
- axitinib
- betaxolol
- Hypoglycaemia: postmarketing
- bicalutamide
- bisoprolol
- bosentan
- bromocriptine
- bupropion
- Hypoglycaemia: postmarketing
- caffeine
- canagliflozin
- carteolol
- carvedilol
- Hypoglycaemia: 0.1% - 1.6%
- cefpodoxime
- celecoxib
- celiprolol
- cevimeline
- chlorpromazine
- chlorpropamide
- cidofovir
- Hypoglycaemia
- Hypoglycemic reaction
- ciprofloxacin
- citalopram
- Hypoglycaemia: postmarketing, rare
- clarithromycin
- Hypoglycaemia: postmarketing
- clopidogrel
- Hypoglycaemia: postmarketing
- colesevelam
- Hypoglycaemia: 3% - 3.45%
- conivaptan
- dalbavancin
- dapagliflozin
- Hypoglycaemia
- Hypoglycemic reaction
- darunavir
- Hypoglycaemia: 1.5% - 3.7%
- deprenyl
- Hypoglycaemia
- Hypoglycemic reaction: rare
- dexmedetomidine
- Hypoglycaemia: postmarketing, common, 5% - 6%
- dextromethorphan
- diclofenac
- didanosine
- Hypoglycaemia: postmarketing
- disopyramide
- donepezil
- Hypoglycaemia: infrequent
- dorzolamide
- doxorubicin
- duloxetine
- Hypoglycaemia: infrequent, frequent
- entacapone
- epinephrine
- ertapenem
- ethacrynic acid
- ethionamide
- everolimus
- exenatide
- Hypoglycaemia: 0% - 43.5%
- felbamate
- fenofibrate
- fentanyl
- fluocinolone acetonide
- fluoxetine
- fluvoxamine
- formoterol
- frovatriptan
- gabapentin
- Hypoglycaemia: infrequent
- gadobenate dimeglumine
- gadolinium
- gadoversetamide
- gatifloxacin
- Hypoglycaemia: postmarketing
- glibenclamide
- gliclazide
- Hypoglycaemia
- Hypoglycaemic episode
- glimepiride
- Hypoglycaemia
- Hypoglycemic reaction
- Hypoglycaemic episode
- glipizide
- glucose solution
- haloperidol
- Hypoglycaemia: very rare, postmarketing
- hydroxychloroquine
- ibuprofen
- Hypoglycaemia: 12%
- Hypoglycemic reaction
- icodextrin
- Hypoglycaemia: postmarketing
- imatinib
- indomethacin
- insulin detemir
- Hypoglycaemia: 0.8% - 1.4%
- Hypoglycaemic episode
- iron sucrose
- isoxsuprine
- ivacaftor
- labetalol
- lamivudine
- lanreotide
- lansoprazole
- lenalidomide
- lercanidipine
- leuprorelin acetate
- levobunolol
- linagliptin
- Hypoglycaemia
- Hypoglycemic reaction
- linezolid
- Hypoglycaemia: postmarketing
- liraglutide
- Hypoglycaemia: postmarketing
- lomefloxacin
- lorcaserin
- losartan
- medroxyprogesterone acetate
- memantine
- Hypoglycaemia: postmarketing
- meropenem
- metformin
- methylphenidate
- Hypoglycaemia: postmarketing
- metoprolol
- mifepristone
- moxifloxacin
- mycophenolate mofetil
- Hypoglycaemia: 9.1% - 10.5%
- mycophenolic acid
- naproxen
- nateglinide
- Hypoglycaemia: common, 0.4% - 2.4%
- nefazodone
- nelarabine
- nelfinavir
- nesiritide
- nilotinib
- norfloxacin
- Hypoglycaemia: postmarketing
- ofloxacin
- Hypoglycaemia: postmarketing
- Hypoglycemic reaction
- olanzapine
- Hypoglycaemia: infrequent
- omeprazole
- Hypoglycaemia: postmarketing
- orlistat
- Hypoglycaemia: postmarketing, uncommon
- oxcarbazepine
- oxprenolol
- oxycodone
- paclitaxel
- paliperidone
- Hypoglycaemia: very rare, postmarketing
- paricalcitol
- paroxetine
- pentamidine
- pergolide
- Hypoglycaemia: infrequent
- perhexiline
- perphenazine
- pilocarpine
- pioglitazone
- Hypoglycaemia: 0% - 30.6%
- piroxicam
- pramipexole
- prednisolone phosphate
- pregabalin
- Hypoglycaemia: infrequent, 1% - 3%
- Hypoglycemic reaction: rare
- prochlorperazine
- propranolol
- quetiapine
- Hypoglycaemia: infrequent
- quinidine
- ramipril
- Hypoglycaemia: postmarketing
- ramiprilat
- Hypoglycaemia: postmarketing
- rapamycin
- repaglinide
- rifapentine
- rifaximin
- rimonabant
- risperidone
- Hypoglycaemia: postmarketing, rare
- rivastigmine
- Hypoglycaemia: infrequent
- ropinirole
- Hypoglycaemia: infrequent
- ropivacaine
- rosiglitazone
- salbutamol
- saquinavir
- sertraline
- Hypoglycaemia: postmarketing, rare
- Hypoglycemic reaction: rare
- sibutramine
- sildenafil
- sitagliptin
- Hypoglycaemia: postmarketing, common
- sitaxsentan
- sodium ferric gluconate
- streptozotocin
- sulfadiazine
- sulfamethoxazole
- sulfasalazine
- sumatriptan
- sunitinib
- tacrolimus
- telavancin
- telmisartan
- Hypoglycaemia: postmarketing, rare
- terbinafine
- testosterone
- Hypoglycaemia: postmarketing
- thalidomide
- thiothixene
- thyroxine
- tiagabine
- Hypoglycaemia: infrequent
- tigecycline
- Hypoglycaemia: postmarketing, common
- timolol
- Hypoglycaemia: postmarketing
- tolazamide
- tolbutamide
- tolvaptan
- topiramate
- tramadol
- Hypoglycaemia: postmarketing
- trifluoperazine
- trimethoprim
- trimethoprim-sulfamethoxazole
- v 1784
- Hypoglycaemia: postmarketing
- vandetanib
- varenicline
- venlafaxine
- Hypoglycaemia: rare, infrequent
- vildagliptin
- Hypoglycaemia: uncommon, common
- vinflunine
- voriconazole
- Hypoglycaemia: postmarketing, common
- zalcitabine
- zaleplon
- Hypoglycaemia: rare
- Hypoglycemic reaction: rare
- ziprasidone
- Hypoglycaemia: rare
- Hypoglycemic reaction: rare
- zonisamide
|
Drugs with this indication
|